These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2083220)

  • 21. Neuropeptides, antagonists and cell proliferation: bombesin as an example.
    Dietrich JB
    Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):731-46. PubMed ID: 7812181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide hormone production in small cell lung carcinomas with particular reference to gastrin-releasing peptide.
    Yamaguchi K; Abe K; Adachi I; Otsubo K; Nagasaki K; Suzuki M; Maruno K; Asanuma F; Tsuchihashi T; Miyake Y
    Jpn J Clin Oncol; 1986 Sep; 16(3):235-41. PubMed ID: 3022032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
    Narayan S; Guo YS; Townsend CM; Singh P
    Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions.
    Siegfried JM; Han YH; DeMichele MA; Hunt JD; Gaither AL; Cuttitta F
    J Biol Chem; 1994 Mar; 269(11):8596-603. PubMed ID: 8132585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
    Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
    Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut hormones, growth and malignancy.
    Baldwin GS; Whitehead RH
    Baillieres Clin Endocrinol Metab; 1994 Jan; 8(1):185-214. PubMed ID: 7907861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer.
    Avis IL; Kovacs TO; Kasprzyk PG; Treston AM; Bartholomew R; Walsh JH; Cuttitta F; Mulshine JL
    J Natl Cancer Inst; 1991 Oct; 83(20):1470-6. PubMed ID: 1656058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal hormones and cell proliferation.
    Townsend CM; Bold RJ; Ishizuka J
    Surg Today; 1994; 24(9):772-7. PubMed ID: 7865952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrin-releasing peptide (GRP, mammalian bombesin) in the pathogenesis of lung cancer.
    Viallet J; Minna JD
    Prog Growth Factor Res; 1989; 1(2):89-97. PubMed ID: 2491257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal hormone research - with a Scandinavian annotation.
    Rehfeld JF
    Scand J Gastroenterol; 2015 Jun; 50(6):668-79. PubMed ID: 25786560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GRP neurones in the rat small intestine issue long anal projections.
    Ekblad E; Ekman R; Håkanson R; Sundler F
    Regul Pept; 1984 Nov; 9(4):279-87. PubMed ID: 6151719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high molecular weight non-bombesin/gastrin releasing peptide growth factor in small cell lung cancer.
    Macaulay V; Joshi GP; Everard M; Smith IE; Millar JL
    Br J Cancer; 1987 Dec; 56(6):791-4. PubMed ID: 2449237
    [No Abstract]   [Full Text] [Related]  

  • 34. The new biology of gastrointestinal hormones.
    Rehfeld JF
    Physiol Rev; 1998 Oct; 78(4):1087-108. PubMed ID: 9790570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung.
    Mulshine JL; Avis I; Treston AM; Kaspryzyk PG; Nakanishi Y; Mobley C; Carrasquillo JA; Larson SM; Merchant B; Cuttitta F
    Int J Rad Appl Instrum B; 1989; 16(2):159-62. PubMed ID: 2541112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine growth factors as therapeutic targets in lung cancer.
    Mulshine JL; Treston AM; Natale RB; Kasprzyk PG; Avis I; Nakanishi Y; Cuttitta F
    Chest; 1989 Jul; 96(1 Suppl):31S-34S. PubMed ID: 2661168
    [No Abstract]   [Full Text] [Related]  

  • 37. The gut as an endocrine organ.
    DelValle J; Yamada T
    Annu Rev Med; 1990; 41():447-55. PubMed ID: 2184742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptides and epithelial growth regulation.
    Goodlad RA; Wright NA
    Experientia; 1987 Jul; 43(7):780-4. PubMed ID: 3297765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal hormones and their targets.
    Rehfeld JF
    Adv Exp Med Biol; 2014; 817():157-75. PubMed ID: 24997033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide YY, a new gut hormone (a mini-review).
    Hill FL; Zhang T; Gomez G; Greeley GH
    Steroids; 1991 Feb; 56(2):77-82. PubMed ID: 2020981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.